Search

Your search keyword '"Stevens-Kroef, Marian"' showing total 3 results
Start Over Author "Stevens-Kroef, Marian" Database OpenAIRE
3 results on '"Stevens-Kroef, Marian"'

1. Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma:results of the HOVON87/NMSG18 study

Author

Stege, Claudia A.M., Kongsgaard Nielsen, Lene, Witte, Birgit, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard, Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette, Deenik, Wendy, Gruber, Astrid, Coenen, Juleon, Plesner, Torben, Klein, Saskia, Tanis, Bea, Szatkowski, Damian L., Brouwer, Rolf, Westerman, Matthijs, Leys, Rineke, Sinnige, Harm, Haukås, Einar, van der Hem, Klaas, Durian, Marc, Mattijssen, Vera, Gimsing, Peter, van de Donk, Niels, Stevens-Kroef, Marian, Sonneveld, Pieter, Waage, Anders, Zweegman, Sonja, and Abildgaard , Niels

Published
2017

2. Guidelines for genomic array analysis in acquired haematological neoplastic disorders

Author

Schoumans, Jacqueline, Suela, Javier, Hastings, Ros, Muehlematter, Dominique, Rack, Katrina, van den Berg, Eva, Beverloo, H. Berna, Stevens-Kroef, Marian, and Clinical Genetics

Subjects
COPY NUMBER ABNORMALITIES, CHRONIC LYMPHOCYTIC-LEUKEMIA, MULTIPLE-MYELOMA, B-CELL PRECURSOR, PROGNOSTIC-SIGNIFICANCE, MYELODYSPLASTIC SYNDROMES, MICROARRAY ANALYSIS, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], IKZF1 DELETION, CHROMOSOME-ABNORMALITIES, ACUTE LYMPHOBLASTIC-LEUKEMIA
Abstract

Item does not contain fulltext Genetic profiling is important for disease evaluation and prediction of prognosis or responsiveness to therapy in neoplasia. Microarray technologies, including array comparative genomic hybridization and single-nucleotide polymorphism-detecting arrays, have in recent years been introduced into the diagnostic setting for specific types of haematological malignancies and solid tumours. It can be used as a complementary test or depending on the neoplasia investigated, also as a standalone test. However, comprehensive and readable presentation of frequently identified complex genomic profiles remains challenging. To assist diagnostic laboratories, standardization and minimum criteria for clinical interpretation and reporting of acquired genomic abnormalities detected through arrays in neoplastic disorders are presented. (c) 2016 Wiley Periodicals, Inc.

Published
2016

3. Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Author

Baron, Frederic, Stevens-Kroef, Marian, Meloni, Giovanna, Muus, Petra, Marie, Jean-Pierre, Halkes, Constantijn, Thomas, Xavier, Vrhovac, Radovan, Specchia, Giorgina, Lefrere, Francois, Sica, Simona, Mancini, Marco, Venditti, Adriano, Hagemeijer, Anne, H. Jansen, Joop, Amadori, Sergio, de Witte, Theo, Willemze, Roelof, Suciu, and Stefan Suciu

Subjects
Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis
Abstract

Background. Previous studies have demonstrated that monosomal karyotype (MK) confers a particularly poor prognosis in patients with acute myeloid leukemia (AML) (Breems et al., J Clin Oncol 2008, 26:4791-7). Purpose of the study. To determine the impact of the type of remission- induction chemotherapy and the impact of having a donor on overall survival (OS) in younger (

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results